JFS Wealth Advisors’s Acer Therapeutics Inc ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-24
| Closed | -$20 | – | 2059 |
|
|
2023
Q3 | $20 | Hold |
24
| – | – | ﹤0.01% | 1957 |
|
|
2023
Q2 | $23 | Hold |
24
| – | – | ﹤0.01% | 1968 |
|
|
2023
Q1 | $19 | Hold |
24
| – | – | ﹤0.01% | 1943 |
|
|
2022
Q4 | $60 | Hold |
24
| – | – | ﹤0.01% | 1912 |
|
|
2022
Q3 | $0 | Hold |
24
| – | – | ﹤0.01% | 1972 |
|
|
2022
Q2 | $0 | Hold |
24
| – | – | ﹤0.01% | 1985 |
|
|
2022
Q1 | $0 | Hold |
24
| – | – | ﹤0.01% | 2008 |
|
|
2021
Q4 | $0 | Hold |
24
| – | – | ﹤0.01% | 1929 |
|
|
2021
Q3 | $0 | Hold |
24
| – | – | ﹤0.01% | 851 |
|
|
2021
Q2 | $0 | Hold |
24
| – | – | ﹤0.01% | 648 |
|
|
2021
Q1 | $0 | Hold |
24
| – | – | ﹤0.01% | 638 |
|
|
2020
Q4 | $0 | Hold |
24
| – | – | ﹤0.01% | 646 |
|
|
2020
Q3 | $0 | Hold |
24
| – | – | ﹤0.01% | 608 |
|
|
2020
Q2 | $0 | Hold |
24
| – | – | ﹤0.01% | 588 |
|
|
2020
Q1 | $0 | Hold |
24
| – | – | ﹤0.01% | 581 |
|
|
2019
Q4 | $0 | Hold |
24
| – | – | ﹤0.01% | 559 |
|
|
2019
Q3 | $0 | Hold |
24
| – | – | ﹤0.01% | 542 |
|
|
2019
Q2 | $0 | Hold |
24
| – | – | ﹤0.01% | 490 |
|
|
2019
Q1 | $1K | Hold |
24
| – | – | ﹤0.01% | 455 |
|
|
2018
Q4 | $0 | Hold |
24
| – | – | ﹤0.01% | 551 |
|
|
2018
Q3 | $1K | Hold |
24
| – | – | ﹤0.01% | 515 |
|
|
2018
Q2 | $1K | Hold |
24
| – | – | ﹤0.01% | 448 |
|
|
2018
Q1 | $0 | Hold |
24
| – | – | ﹤0.01% | 578 |
|
|
2017
Q4 | $0 | Hold |
24
| – | – | ﹤0.01% | 562 |
|
|
2017
Q3 | $0 | Hold |
24
| – | – | ﹤0.01% | 462 |
|
|
2017
Q2 | $0 | Hold |
24
| – | – | ﹤0.01% | 456 |
|
|
2017
Q1 | $0 | Hold |
24
| – | – | ﹤0.01% | 445 |
|
|
2016
Q4 | $0 | Hold |
24
| – | – | ﹤0.01% | 494 |
|
|
2016
Q3 | $1K | Hold |
24
| – | – | ﹤0.01% | 468 |
|
|
2016
Q2 | $1K | Buy |
+24
| New | +$714 | ﹤0.01% | 483 |
|
Other funds holding ACER
JFS Wealth Advisors's ACER Position: Q4 2023 in Review
JFS Wealth Advisors sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 24 shares — an estimated $20 sold.
JFS Wealth Advisors first reported a position in ACER in Q2 2016 and held it in 30 quarters. The position peaked at $1K in Q1 2019. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.
- JFS Wealth Advisors reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
- JFS Wealth Advisors sold 24 Acer Therapeutics Inc shares in Q4 2023, an estimated $20.
- JFS Wealth Advisors first reported a position in Acer Therapeutics Inc in Q2 2016 and held it in 30 quarters.
- JFS Wealth Advisors's Acer Therapeutics Inc position peaked at $1K in Q1 2019.
- 2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.
Based on JFS Wealth Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.